Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

British researchers describe anticytokine antisense peptides

Dec. 30, 1996

Biomatrix-Boehringer Ingelheim Synvisc agreement

Dec. 23, 1996

ConXn effective in lung fibrosis

Dec. 20, 1996

GLA effective in treating active rheumatoid arthritis

Dec. 18, 1996

Anti-L-selectin aptamers demonstrate efficacy in animals

Dec. 18, 1996

ML-3000 progresses through the pipeline

Dec. 18, 1996

Antiinflammatory glycolipid compounds from Nissin Food Products

Dec. 16, 1996

MMP/TNF inhibitors reported by Pfizer

Dec. 12, 1996

New antiinflammatory agents disclosed by DuPont Merck

Dec. 10, 1996

Another British Biotech compound reaches clinical stage

Dec. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...